Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Chesnara ( (GB:CSN) ) has shared an update.
Chesnara plc said all resolutions at its 2026 annual general meeting were approved by substantial majorities, including the adoption of the 2025 accounts, the remuneration report and policy, and the declaration of a final dividend of 14.8p per share. Shareholders also backed the reappointment and appointment of directors, renewed authorities to allot shares and disapply pre-emption rights, authorised share buybacks and the issuance of Restricted Tier 1 instruments, and confirmed the company’s ability to call meetings on 14 days’ notice, reinforcing board flexibility and capital management options.
The AGM results showed strong investor support for the board and its strategy, with most resolutions receiving over 98% of votes cast in favour despite some dissent on pay policy and pre-emption disapplications. Chesnara reported an issued share capital of 230,974,321 ordinary shares, with each share carrying one vote, underscoring a stable shareholder base as the group continues its long-standing dividend growth record and consolidation-led growth model.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.20 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Spark’s Take on CSN Stock
According to Spark, TipRanks’ AI Analyst, CSN is a Neutral.
The score is held back primarily by inconsistent profitability and especially unstable cash flow, despite a currently strong balance sheet. Technically, the stock shows a weak trend (below key moving averages and negative MACD), while valuation is supported by a very high dividend yield but tempered by negative earnings (negative P/E).
To see Spark’s full report on CSN stock, click here.
More about Chesnara
Chesnara plc is a FTSE 250 European life, pensions and investment company with specialist expertise in insurance consolidation. It administers about 1.4 million policies through Countrywide Assured and Chesnara Life in the UK, Scildon in the Netherlands and Movestic in Sweden, focusing on efficient policy administration, selective new business and value-adding acquisitions.
Average Trading Volume: 746,684
Technical Sentiment Signal: Buy
Current Market Cap: £721.8M
Find detailed analytics on CSN stock on TipRanks’ Stock Analysis page.

